Associations between epidermal growth factor receptor mutations and histological subtypes of lung adenocarcinoma according to the IASLC/ATS/ERS classification in Chinese patients
- PMID: 28940943
- PMCID: PMC5668489
- DOI: 10.1111/1759-7714.12489
Associations between epidermal growth factor receptor mutations and histological subtypes of lung adenocarcinoma according to the IASLC/ATS/ERS classification in Chinese patients
Abstract
Background: This retrospective study was conducted to investigate the relationship between epidermal growth factor receptor (EGFR) mutation and histological subtypes of lung adenocarcinoma according to the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society (IASLC/ATS/ERS) classification in Chinese patients.
Methods: Three hundred and seventy six surgically resected lung adenocarcinomas from Chinese PLA General Hospital were included in the study. Patients' clinical and pathological characteristics including age, gender, smoking history, tumor size, tumor node metastasis stage, and tumor differentiation were analyzed. Histologic subtypes of adenocarcinoma were categorized according to the IASLC/ATS/ERS classification of lung adenocarcinoma. An amplification-refractory mutation system was performed to detect EGFR mutations.
Results: One hundred and fifty three lung adenocarcinomas had EGFR mutations. In univariate analysis, EGFR mutations were associated with gender (P < 0.001), smoking history (P < 0.001), tumor differentiation (P < 0.001), and acinar predominant (P < 0.001), papillary predominant (P = 0.034), solid predominant (P = 0.022), invasive mucinous (P = 0.012) and mucinous (P = 0.001) subtypes.
Conclusions: In Chinese patients with lung adenocarcinoma, smoking history, tumor differentiation, and acinar predominant and mucinous subtypes were independent predictors of EGFR mutation.
Keywords: EGFR mutation; lung adenocarcinoma; pathology.
© 2017 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd.
Similar articles
-
Associations between the IASLC/ATS/ERS lung adenocarcinoma classification and EGFR and KRAS mutations.Pathology. 2016 Jan;48(1):17-24. doi: 10.1016/j.pathol.2015.11.002. Epub 2015 Dec 12. Pathology. 2016. PMID: 27020204
-
Correlation between EML4-ALK, EGFR and clinicopathological features based on IASLC/ATS/ERS classification of lung adenocarcinoma.Medicine (Baltimore). 2018 Jun;97(26):e11116. doi: 10.1097/MD.0000000000011116. Medicine (Baltimore). 2018. PMID: 29952952 Free PMC article.
-
Relevance of EGFR mutation with micropapillary pattern according to the novel IASLC/ATS/ERS lung adenocarcinoma classification and correlation with prognosis in Chinese patients.Lung Cancer. 2014 Nov;86(2):164-9. doi: 10.1016/j.lungcan.2014.08.018. Epub 2014 Sep 8. Lung Cancer. 2014. PMID: 25236981
-
Association between the novel classification of lung adenocarcinoma subtypes and EGFR/KRAS mutation status: A systematic literature review and pooled-data analysis.Eur J Surg Oncol. 2019 May;45(5):870-876. doi: 10.1016/j.ejso.2019.02.006. Epub 2019 Feb 16. Eur J Surg Oncol. 2019. PMID: 30833014
-
Lung Adenocarcinoma Staging Using the 2011 IASLC/ATS/ERS Classification: A Pooled Analysis of Adenocarcinoma In Situ and Minimally Invasive Adenocarcinoma.Clin Lung Cancer. 2016 Sep;17(5):e57-e64. doi: 10.1016/j.cllc.2016.03.009. Epub 2016 Mar 30. Clin Lung Cancer. 2016. PMID: 27137345 Review.
Cited by
-
Invasive mucinous adenocarcinoma of the lung.Transl Cancer Res. 2019 Dec;8(8):2924-2932. doi: 10.21037/tcr.2019.11.02. Transl Cancer Res. 2019. PMID: 35117050 Free PMC article. Review.
-
Clinical features and prognostic nomogram development for cancer-specific death in patients with dual primary lung cancer: a population-based study from SEER database.J Cardiothorac Surg. 2025 Apr 11;20(1):190. doi: 10.1186/s13019-025-03385-y. J Cardiothorac Surg. 2025. PMID: 40217288 Free PMC article.
-
Real-world clinical analysis in 190 advanced NSCLC patients with uncommon EGFR mutations: A multi-center study.Cancer Sci. 2023 Jun;114(6):2552-2559. doi: 10.1111/cas.15769. Epub 2023 Mar 12. Cancer Sci. 2023. PMID: 36851884 Free PMC article.
-
Prognostic analysis of patients with mutant and wild-type EGFR gene lung adenocarcinoma.Cancer Manag Res. 2019 Jul 4;11:6139-6150. doi: 10.2147/CMAR.S200126. eCollection 2019. Cancer Manag Res. 2019. PMID: 31308750 Free PMC article.
-
Association of histologic subtypes with genetic alteration and PD-L1 expression in pulmonary adenocarcinoma.Mol Clin Oncol. 2020 Sep;13(3):12. doi: 10.3892/mco.2020.2082. Epub 2020 Jul 1. Mol Clin Oncol. 2020. PMID: 32754326 Free PMC article.
References
-
- Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. (Published erratum appears in CA Cancer J Clin 2011; 61: 134.) CA Cancer J Clin 2011; 61: 69–90. - PubMed
-
- Shin HR, Masuyer E, Ferlay J, Curado MP. Asian contributors to CI5 IX4. Cancer in Asia – Incidence rates based on data in cancer incidence in five continents IX (1998–2002). Asian Pac J Cancer Prev 2010; 11 (Suppl. 2): 11–6. - PubMed
-
- Pao W, Miller VA. Epidermal growth factor receptor mutations, small‐molecule kinase inhibitors, and non‐small‐cell lung cancer: Current knowledge and future directions. J Clin Oncol 2005; 23: 2556–68. - PubMed
-
- Yanagawa N, Shiono S, Abiko M, Ogata SY, Sato T, Tamura G. The correlation of the international association for the study of lung cancer (IASLC)/american thoracic society (ATS)/european respiratory society (ERS) classification with prognosis and EGFR mutation in lung adenocarcinoma. Ann Thorac Surg 2014; 98: 453–8. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous